Identification of a novel PHGDH covalent inhibitor by chemical proteomics and phenotypic profiling
Open Access
- 16 June 2021
- journal article
- research article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 12 (1) , 246-261
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20181329)
- Program for Changjiang Scholars and Innovative Research Team in University (IRT_15R63)
- National Natural Science Foundation of China (81872983, 81903861)
This publication has 41 references indexed in Scilit:
- The PHGDH enigma: Do cancer cells only need serine or also a redox modulator?Cancer Letters, 2020
- Metabolic regulation of cell growth and proliferationNature Reviews Molecular Cell Biology, 2019
- D-3-Phosphoglycerate DehydrogenaseFrontiers in Molecular Biosciences, 2018
- Cancer Metabolism: Current Understanding and TherapiesChemical Reviews, 2018
- Serine and Functional Metabolites in CancerTrends in Cell Biology, 2017
- Serine and one-carbon metabolism in cancerNature Reviews Cancer, 2016
- The importance of serine metabolism in cancerJournal of Cell Biology, 2016
- Serine and glycine metabolism in cancerTrends in Biochemical Sciences, 2014
- Serine, glycine and one-carbon units: cancer metabolism in full circleNature Reviews Cancer, 2013
- Genetically-defined metabolic reprogramming in cancerTrends in Endocrinology & Metabolism, 2012